Nitration and Functional Loss of Voltage-Gated K
Channels in Rat Coronary Microvessels Exposed to
High Glucose
Hongwei Li,
1
David D. Gutterman,
2,3
Nancy J. Rusch,
3,4
Aaron Bubolz,
2,3
and Yanping Liu
2,3
Coronary microvessels generate reactive oxygen spe-
cies in response to high glucose (HG), resulting in
vasodilator defects involving an impaired function of
vascular K
channels. Inhibition of voltage-gated K
(K
v
) channels by peroxynitrite (ONOO
), formed by the
interaction of superoxide and nitric oxide, may contrib-
ute to impaired dilation. The present study investigated
whether HG induces ONOO
formation to mediate ni-
tration and impairment of K
v
channels in rat small
coronary arteries (RSCAs). Exposure to ONOO
re-
duced the dilator influence of K
v
channels in RSCAs.
Patch-clamp studies revealed that ONOO
diminished
whole-cell and unitary K
v
currents attributable to the
K
v
1 gene family in smooth muscle cells. Subsequently,
immunohistochemically detected enhancement of nitro-
tyrosine residues in RSCAs that were cultured in HG
(23 mmol/l) compared with normal glucose (5.5 mmol/l)
for 24 h correlated with the nitration of K
v
1.2 channel
-subunits. HG-induced nitrotyrosine formation was par-
tially reversed by scavenging ONOO
. Finally, RSCAs
that were exposed to HG for 24 h showed a loss of K
v
channel dilator influence that also was partially re-
stored by the ONOO
scavengers urate and ebselen. We
conclude that ONOO
generated by HG impairs K
v
channel function in coronary microvessels, possibly by
nitrating tyrosine residues in the pore-forming region of
the K
v
channel protein. Diabetes 53:2436 –2442, 2004
I
n type 2 diabetes, endothelium-dependent vasodila-
tor responses are impaired in both the macro- and
the microvasculature, possibly related to the forma-
tion of reactive oxygen species (ROS). The presence
of hyperglycemia per se fosters the local formation of
superoxide (O
2
˙
-
) (1,2), which may interact with nitric
oxide (NO) to form the highly reactive oxidant peroxyni-
trite (ONOO
-
). Indeed, recent evidence has emphasized
that NO derived from inducible NO synthase under condi-
tions of high glucose (HG) may contribute to vasodilator
dysfunction by driving the generation of ONOO
-
(3). In
turn, ONOO
-
may promote oxidative and nitrosative tis-
sue damage (4), in part by nitration of tyrosine residues to
impair the function of multiple proteins, including K
+
channels that mediate vasodilation (5,6).
In this regard, most studies have focused on ONOO
-
-
induced inhibition of high-conductance Ca
2+
-activated K
+
(K
Ca
) channels as a mechanism of vasodilator impairment
(5,6). However, a targeted inhibition of K
Ca
channels by
ONOO
-
cannot account for some of the profound vasodi-
lator defects that are induced by HG and seem to relate
more closely to an impaired function of voltage-gated K
+
(K
v
) channels. For example, vasodilator responses to
forskolin and isoproterenol rely on cAMP-induced activa-
tion of K
v
channels to mediate relaxation, but these
responses are markedly blunted in rat small coronary
arteries (RSCAs) that are exposed to HG for 24 h (7). In
addition, the activity and expression levels of K
v
channels
are sensitive to oxidant stress (8), and although K
v
chan-
nels emanate from at least 11 gene families (K
v
1–K
v
11), the
K
v
1 “Shaker-type” family channels that are densely ex-
pressed in vascular smooth muscle cells (VSMCs) may be
particularly susceptible to open-channel block by redox
agents (9,10). Collectively, these findings provide a com-
pelling reason to investigate whether ROS associated with
HG alter K
v
channel function. The present study tested the
hypothesis that HG induces endogenous ONOO
-
forma-
tion in RSCAs, resulting in nitration and impairment of K
v
channels and vasodilator function.
RESEARCH DESIGN AND METHODS
Preparation of RSCAs. Seven-week-old male Sprague-Dawley rats (Harlan,
Madison, WI) were anesthetized with sodium pentobarbital (60 mg/kg i.p.).
RSCAs (internal diameter 150 –200 m) were dissected from the left ventricle.
Some RSCAs were incubated in culture media supplemented with either 5.5
mmol/l D-glucose (normal glucose [NG]) or 23 mmol/l D-glucose (high glucose
[HG]), or 5.5 mmol/l D-glucose plus 17.5 mmol/l L-glucose (LG) for osmotic
control as described previously (11). All rats were housed in the Association
for Assessment and Accreditation of Laboratory Animal Care–approved
Biomedical Resource Center at the Medical College of Wisconsin, and all
protocols were approved by the Animal Care Committee.
Formation of ONOO
. Authentic ONOO
-
was synthesized according to
published methods (5,6). The amount of ONOO
-
in the stock solution was
determined spectrophotometrically using the reported extinction coefficient
for ONOO
-
(1,670 mol l
-1
cm
-1
). Before each application, an aliquot of the
stock solution was diluted in 1 mmol/l NaOH and rapidly added to the vessel
chamber to achieve a final concentration of 5 mol/l. Decomposed ONOO
-
From the
1
Heart and Vessel Diseases Center, Beijing Friendship Hospital,
Affiliate of Capital University of Medical Sciences, Beijing, People’s Republic
of China;
2
Department of Medicine, The Medical College of Wisconsin and The
Veterans Administration Medical Center, Milwaukee, Wisconsin; the
3
Cardio-
vascular Center, The Medical College of Wisconsin and The Veterans Admin-
istration Medical Center, Milwaukee, Wisconsin; and the
4
Department of
Pharmacology & Toxicology, The Medical College of Wisconsin and The
Veterans Administration Medical Center, Milwaukee, Wisconsin.
Address correspondence and reprint requests to Yanping Liu, MD, PhD,
Cardiovascular Center, Medical College of Wisconsin, 8701 Watertown Plank
Rd., Milwaukee, WI 53226. E-mail: ypliu@mcw.edu.
Received for publication 19 March 2004 and accepted in revised form 8 June
2004.
4-AP, 4-aminopyridine; COR, correolide; HG, high glucose; K
Ca
, Ca
2+
-acti-
vated K
+
;K
v
, voltage-gated K
+
; LG, L-glucose; L-NAME, N
-nitro-L-arginine
methyl ester; MnTBAP, manganese [III] tetrakis 4-benzoic acid porphyrin; NG,
normal glucose; ROS, reactive oxygen species; RSCA, rat small coronary
artery; VSMC, vascular smooth muscle cell.
© 2004 by the American Diabetes Association.
2436 DIABETES, VOL. 53, SEPTEMBER 2004